Active Ingredient History

NOW
  • Now
Dipyridamole, a non-nitrate coronary vasodilator that also inhibits platelet aggregation, is combined with other anticoagulant drugs, such as warfarin, to prevent thrombosis in patients with valvular or vascular disorders. Dipyridamole is also used in myocardial perfusion imaging, as an antiplatelet agent, and in combination with aspirin for stroke prophylaxis. Dipyridamole likely inhibits both adenosine deaminase and phosphodiesterase, preventing the degradation of cAMP, an inhibitor of platelet function. This elevation in cAMP blocks the release of arachidonic acid from membrane phospholipids and reduces thromboxane A2 activity. Dipyridamole also directly stimulates the release of prostacyclin, which induces adenylate cyclase activity, thereby raising the intraplatelet concentration of cAMP and further inhibiting platelet aggregation. Used for as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement and also used in prevention of angina.   NCATS

  • SMILES: OCCN(CCO)C1=NC2=C(N=C(N=C2C(=N1)N3CCCCC3)N(CCO)CCO)N4CCCCC4
  • InChIKey: IZEKFCXSFNUWAM-UHFFFAOYSA-N
  • Mol. Mass: 504.6256
  • ALogP: -0.02
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$1.5123 - $19.6000
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

attia | cardoxil | cardoxin | cerebrovase 100 | cerebrovase 25 | cleridium | cleridium 150 | crx-102 | curantyl | dipiridamol | dipyramidole | dipyridamine | dipyridamol | dipyridamole | dipyridamolum | dipyridan | dipyudamine | dypyridamol | iv persantine | modaplate | ofcram pr | peridamol | persantin | persantine | persantin ret | pyridantin | ra-8 | stenocardil | stimolcardio | vasyrol

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue